SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-045375
Filing Date
2019-12-05
Accepted
2019-12-05 16:28:06
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q caba-10q_20190930.htm 10-Q 2214384
2 EX-10.4 caba-ex104_188.htm EX-10.4 19516
3 EX-31.1 caba-ex311_142.htm EX-31.1 20170
4 EX-31.2 caba-ex312_141.htm EX-31.2 20147
5 EX-32.1 caba-ex321_139.htm EX-32.1 10653
6 EX-32.2 caba-ex322_140.htm EX-32.2 10752
  Complete submission text file 0001564590-19-045375.txt   5826921

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT caba-20190930.xml EX-101.INS 968958
8 XBRL TAXONOMY EXTENSION SCHEMA caba-20190930.xsd EX-101.SCH 46100
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caba-20190930_cal.xml EX-101.CAL 28293
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caba-20190930_def.xml EX-101.DEF 155283
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20190930_lab.xml EX-101.LAB 346556
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20190930_pre.xml EX-101.PRE 264375
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 191270664
SIC: 2836 Biological Products, (No Diagnostic Substances)